PRMB:NYSEPrimo Brands Corporation Analysis
Data as of 2026-09-01 - not real-time
$22.82
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Primo Brands Corporation is neutral at $22.82, with no clear ordering between short and long averages. Over a rolling month the price has lost 6.1%. With RSI at 44.4 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near $22.26 and resistance around $26.21.
Multiples put this in fair territory at a P/E of 76.1. Sell-side targets cluster 33.1% above the current quote. Revenue is growing at 3.8% on a 1.5% profit margin. The 2.09% dividend yield looks stretched against payout coverage.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 43.5%, a beta of 0.87 and a maximum drawdown of 42.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Multiples put this in fair territory at a P/E of 76.1. Sell-side targets cluster 33.1% above the current quote. Revenue is growing at 3.8% on a 1.5% profit margin. The 2.09% dividend yield looks stretched against payout coverage.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 43.5%, a beta of 0.87 and a maximum drawdown of 42.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Top Market Events
/CNW/ -- Primo Brands Corporation NYSE: PRMB "Primo Brands" or the "Company" today announced that one of its...Primo Brands raised its full-year comparable sales growth outlook to 2%-4% for the second straight quarter, with Direct...Primo Brands Corporation NYSE: PRMB "Primo Brands" or the "Company" today announced its results for the second quarter...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading above the 200-day average of 20.60
- MACD momentum is negative
- 30-day price change of -6.1%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Dividend yield of 2.09% looks stretched against payout coverage
- Trading above the 200-day average of 20.60
- Analyst targets imply +33.1% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Dividend yield of 2.09% looks stretched against payout coverage
- Analyst targets imply +33.1% versus the current price
- P/E ratio of 76.1
Key Metrics & Analysis
Financial Health
Revenue Growth3.80%
Profit Margin1.49%
P/E Ratio76.1
ROE3.59%
ROA4.16%
Debt/Equity191.16
P/B Ratio2.8
Op. Cash Flow$823.0M
Free Cash Flow$403.3M
Technical Analysis
TrendNeutral
RSI44.4
Support$22.26
Resistance$26.21
MA 20$23.59
MA 50$23.84
MA 200$20.60
MACDBearish
VolumeDecreasing
Fear & Greed Index94.79
Valuation
Fair Value$1.98
Target Price$30.36
Upside/Downside33.06%
GradeFair
TypeBlend
Dividend Yield2.09%
Risk Assessment
Beta0.87
Volatility43.48%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.